D:发行公告
3:首次持股声明-董事 Neuman John
4:持股变动声明-高管 Green David A
4:持股变动声明-董事 Russell Richard D.
4:持股变动声明-董事 Lobo Andres
4:持股变动声明-董事 Barnett Rick
4:持股变动声明-董事 Van Heel Kenneth
4:持股变动声明-董事 Collins Allan
4:持股变动声明-董事 Rodgers Bruce M.
SEASTAR MEDICAL HOLDING CORP C/WTS 28/10/2027 (TO PUR COM) | SC 13G/A:超过5%持股股东披露文件(修正)-Vellar Opportunities Fund Master, Ltd.(0.0%),Cohen & Company LLC(0.0%)等
SEASTAR MEDICAL HOLDING CORP C/WTS 28/10/2027 (TO PUR COM) | 3:首次持股声明-高管 Green David A
SEASTAR MEDICAL HOLDING CORP C/WTS 28/10/2027 (TO PUR COM) | 4:持股变动声明-首席执行官 Schlorff Eric
SEASTAR MEDICAL HOLDING CORP C/WTS 28/10/2027 (TO PUR COM) | 4:持股变动声明-高管 Chung Kevin
SEASTAR MEDICAL HOLDING CORP C/WTS 28/10/2027 (TO PUR COM) | 4:持股变动声明-高管 Baron Caryl
SEASTAR MEDICAL HOLDING CORP C/WTS 28/10/2027 (TO PUR COM) | 4/A:持股变动声明(修正)-高管 Chung Kevin
SEASTAR MEDICAL HOLDING CORP C/WTS 28/10/2027 (TO PUR COM) | 4/A:持股变动声明(修正)-首席执行官 Schlorff Eric
SEASTAR MEDICAL HOLDING CORP C/WTS 28/10/2027 (TO PUR COM) | 4/A:持股变动声明(修正)-首席执行官 Schlorff Eric
SEASTAR MEDICAL HOLDING CORP C/WTS 28/10/2027 (TO PUR COM) | 4:持股变动声明-董事 Van Heel Kenneth
SEASTAR MEDICAL HOLDING CORP C/WTS 28/10/2027 (TO PUR COM) | 4:持股变动声明-高管 Baron Caryl
SEASTAR MEDICAL HOLDING CORP C/WTS 28/10/2027 (TO PUR COM) | 4:持股变动声明-高管 Chung Kevin
暂无数据